OutPerformDaily

  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks

Lost Password?
Alphabet’s 2025 Review: The Four Developments That Mattered Most for Investors

Alphabet’s 2025 Review: The Four Developments That Mattered Most for Investors

Capital One’s mixed quarter doesn’t change our view on its budding transformation

4 Top Artificial Intelligence Stocks to Buy Right Now

Intel Q4 Earnings Call Highlights

Intel stock plunges 13% on soft guidance, concerns about chip production

Nuclear Play for 2026 and Beyond: Should You Buy Cameco Stock While It’s Below $125?

Nuclear Play for 2026 and Beyond: Should You Buy Cameco Stock While It’s Below $125?

OutPerformDaily
  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks
OutPerformDaily
  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks
3rdPartyFeeds • News

The Wall Street Journal: Catalent to buy Paragon Bioservices in $1.2 billion gene-therapy-drug deal

April 14, 2019

Contract drug manufacturer Catalent Inc. agreed to buy closely held Paragon Bioservices Inc. for $1.2 billion, according to people familiar with the matter...

3rdPartyFeeds

Forget Canopy Growth: This Marijuana Stock Is Much Better

April 14, 2019

For real earnings, you need to head south of the border. Read More...

3rdPartyFeeds

Netflix Has a Lot to Prove This Week

April 14, 2019

The world's leading premium streaming video service kicks off tech's earnings season on Tuesday. There are a lot of moving parts to consider. Read...

3rdPartyFeeds

As Apple’s stock rides high, 7 reasons investors should worry

April 14, 2019

Apple seems to be doing well: it’s once again the most valuable U.S. company, with a stock-market value of around $945 billion and its shares trading around...

3rdPartyFeeds

Netflix CEO Reed Hastings Was Right About Disney+

April 14, 2019

The so-called "Netflix killer" is anything but. Read More...

3rdPartyFeeds

Why Netflix May Be Buying a Classic Hollywood Theater

April 14, 2019

The streaming service really, really wants to get Oscars and this effort may help them stay eligible. Read More...

3rdPartyFeeds • News

The Margin: Tiger Woods wins the Masters, and Nike was ready to capitalize on it

April 14, 2019

Tiger Woods just completed one of the greatest comebacks in the history of sports, battling back from an injury- and scandal-ridden decade that almost derailed...

International • Tech Stocks

Walmart’s Ad Tech In-Housing Continues With Deal For Polymorph Labs.

April 14, 2019

Walmart Media Group (WMG), the retailer’s data-driven advertising business, took another step forward with it’s in-house advertising program on Thursday with...

3rdPartyFeeds • News

FA Center: 4 ways we don’t make rational money decisions as we reach retirement

April 14, 2019

Nudging people to make more rational decisions as they enter retirement is more challenging than nudging them to save more while working.

Read More...

3rdPartyFeeds • News

Key Words: Donald Trump: The stock market should be as much as 10,000 points higher

April 14, 2019

The value of the U.S. stock market has risen by $9.1 trillion, or 35.6%, since Election Day in 2016, according to Wilshire Associates. For President Donald...

Previous 1 … 8,357 8,358 8,359 8,360 8,361 … 8,407 Next
Indices by TradingView
Alphabet’s 2025 Review: The Four Developments That Mattered Most for Investors

Alphabet’s 2025 Review: The Four Developments That Mattered Most for Investors

January 22, 2026

Capital One’s mixed quarter doesn’t change our view on its budding transformation

January 22, 2026

4 Top Artificial Intelligence Stocks to Buy Right Now

January 22, 2026

Intel Q4 Earnings Call Highlights

January 22, 2026

Intel stock plunges 13% on soft guidance, concerns about chip production

January 22, 2026

Categories

  • 3rdPartyFeeds
  • Cannabis Stocks
  • Index Funds
  • International
  • News
  • Short
  • Stock Picks
  • Tech Stocks
  • Uncategorized
Indices by TradingView
While subscribers receive the benefit of Outperformdaily opinions, none of the information contained therein constitutes a recommendation from Outperformdaily that any particular security, portfolio of securities, transaction, option, or investment strategy is suitable for any specific person. You further understand that we will not advise you personally concerning the nature, potential, value or suitability of any particular security, portfolio of securities, transaction, investment strategy or other matter. To the extent any of the information contained in Outperformdaily may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person. Outperformdaily’s past results are not necessarily indicative of future performance. All investments are subject to loss. Our employees and writters typically personally invest in all recommendations, but they are not obligated too. Our employees and writters are prohibited from taking an opposite position from which they write about.